Many global, regional, and local vendors characterize the biopsy device market. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, product quality, reliability, and government regulations. Vendors must provide cost-efficient, high-quality polyamide products to survive and succeed in an intensely competitive market.
The market vendors’ growth depends on market conditions, government support, and industry development. Thus, the vendors should focus on expanding geographically and improving services. Argon Medical Devices, BD, Cook Medical, CONMED Corporation, Olympus Corporation, Hologic, Inc., Cardinal Health Inc., Integra LifeSciences, Medtronic plc, Mammotome, INRAD, and Trivitron Healthcare are the major companies in the market which compete in terms of availability, quality, price, and technology. They primarily focus on the development of biopsy device products. Although international players dominate the market, regional and foreign players with small market shares also have a presence. The international players may strengthen their presence worldwide through acquisitions during the forecast period.
Threat Of New Entrants
The threat of new entrants in the biopsy devices market is moderate. Any company manufacturing biopsy devices is required to accept and abide by the mandatory regulatory standards set by the respective regulatory authorities of a country, such as the United States Food and Drug Administration (FDA), European Medicines Agency (EMA), The Central Drugs Standard Control Organization (CDSCO), and others. However, huge opportunities in the market have encouraged many players to invest in this lucrative market. Moreover, supportive government policies and a rising number of investors have impulse entrepreneurs to enter the handheld surgical device industry. These factors are responsible for minimizing the entry barriers for new players, which can be a major threat to the current companies.
Bargaining Power of Suppliers
The global biopsy devices market suppliers are the developers and manufacturers of biopsy devices such as forceps, retractors, graspers, and others used in various general surgical procedures. The bargaining power of suppliers is a crucial factor in the biopsy devices market and determines the industry's strength. Many suppliers are currently present in the market due to the high demand for biopsy devices and increasing government support. The existing key companies capture significant market share and monitor the costs of biopsy devices. The switching cost of these suppliers is moderate because suppliers tend to enter long-term associations, partnerships, and deals with other handheld surgical device manufacturing companies. Thus, the overall bargaining power of suppliers in the global biopsy devices market is expected to be moderate during the forecast period.
Threat of Substitutes
Biopsy devices are reliable, cost-effective products such as scalpels, forceps, retractors, and others used in various general surgical procedures. Furthermore, many large and medium-scale companies manufacture different types of products for different application. Some small companies provide their products at low prices to sustain themselves in this highly competitive market. Thus, the overall threat of substitutes in the global biopsy devices market is expected to be moderate-to-low during the forecast period.
Bargaining Power of Buyers
The global biopsy devices market is characterized by the presence of a large number of buyers. The market for biopsy devices is identified as having a significant customer base, considering the increasing number of patients suffering from chronic diseases and the increasing use of products for various biopsy procedures. However, the buyers tend to use the products that have been provided by the top players irrespective of the pricing. Thus, the bargaining power of buyers is expected to be moderate in the global biopsy devices market during the forecast period.
Intensity of Rivalry
The overall degree of competition in the global biopsy devices market is high. The reserved degree of product differentiation among existing players increases the intensity of rivalry in the market. The companies engaged in manufacturing biopsy devices are developing advanced products for differentiating their brand from the competitors. Additionally, many prominent market players are entering into strategic partnerships, co-development activities, and tie-ups with established companies to overcome the competition. Thus, the intensity of rivalry in the global biopsy devices market is expected to be high during the study period.
